Oramed Pharmaceuticals (ORMP) Treasury Shares (2015 - 2025)
Oramed Pharmaceuticals' (ORMP) quarterly Treasury Shares came in at $4.4 million in Q4 2025, up 70.43% YoY from $2.6 million in Q4 2024, and up 70.43% on a QoQ basis from $2.6 million in Q4 2024.
Oramed Pharmaceuticals (ORMP) Treasury Shares (2015 - 2025) Analysis & Trends
Oramed Pharmaceuticals (ORMP) has 11 years of Treasury Shares data on file, last reported at $4.4 million in Q4 2025.
- Quarterly Treasury Shares rose 70.43% year-over-year to $4.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.4 million (up 70.43% YoY) and the FY2025 annual result came in at $4.4 million, up 70.43% from the prior year.
- Treasury Shares climbed to $4.4 million in Q4 2025, from $2.6 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $7.5 million in Q2 2022 to a low of $539452.0 in Q3 2024.
- A 5-year average of $2.8 million and a median of $1.8 million in 2023 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2021 — Treasury Shares surged 459.6% — and 2023, when it climbed 17.47%.
- Tracing ORMP's Treasury Shares over 5 years: stood at $921302.0 in 2021, then jumped by 69.5% to $1.6 million in 2022, then gained by 17.47% to $1.8 million in 2023, then surged by 40.22% to $2.6 million in 2024, then soared by 70.43% to $4.4 million in 2025.
- The last three Treasury Shares figures came in at $4.4 million (Q4 2025), $2.6 million (Q4 2024), and $539452.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Oramed Pharmaceuticals | 197.61 Mn | 197.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.38 Mn |
| Dec 31, 2025 | 4.38 Mn |
| Dec 31, 2024 | 2.57 Mn |
| Dec 31, 2024 | 2.57 Mn |
| Sep 30, 2024 | 539,452.00 |
| Sep 30, 2024 | 539,452.00 |
| Dec 31, 2023 | 1.83 Mn |
| Dec 31, 2023 | 1.83 Mn |
| Dec 31, 2022 | 1.56 Mn |
| Dec 31, 2022 | 1.56 Mn |
| Jun 30, 2022 | 7.50 Mn |
| Jun 30, 2022 | 7.50 Mn |
| Aug 31, 2021 | 921,302.00 |
| Aug 31, 2021 | 921,302.00 |
| Aug 31, 2020 | 164,636.00 |
| Aug 31, 2020 | 164,636.00 |
| Aug 31, 2019 | 164,636.00 |
| Aug 31, 2019 | 164,636.00 |
| Aug 31, 2018 | 165,796.00 |
| Aug 31, 2018 | 165,796.00 |